| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 10.168 | 9.166 | 5.415 | 201 |
| Total Income - EUR | - | - | - | - | - | - | 10.168 | 9.166 | 5.415 | 201 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.667 | 22.713 | 10.785 | 10.974 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 4.501 | -13.546 | -5.370 | -10.773 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 4.196 | -13.821 | -5.370 | -10.773 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Corymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.001 | 42.649 | 50.288 | 47.238 |
| Current Assets | - | - | - | - | - | - | 17.638 | 2.573 | 577 | 2.897 |
| Inventories | - | - | - | - | - | - | 0 | 228 | 0 | 2.621 |
| Receivables | - | - | - | - | - | - | 0 | 459 | 23 | 23 |
| Cash | - | - | - | - | - | - | 17.638 | 1.886 | 554 | 253 |
| Shareholders Funds | - | - | - | - | - | - | 4.236 | -9.572 | -14.913 | -25.603 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 15.402 | 54.795 | 65.777 | 75.738 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Corymed S.r.l.